We found that high expression levels of PGAM1 and PGAM4 in lung adenocarcinoma (LUAD) patients and NOL6 in lung squamous cell carcinoma (LUSC) patients were associated with low overall survival rates. Here, PGAM4 is linked to squamous cell lung carcinoma.